Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 15, 2025

LyondellBasell avança na liderança em sustentabilidade no Relatório de Sustentabilidade de 2024: Da Visão ao Valor
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- A LyondellBasell (NYSE: LYB), líder global na indústria química, divulgou hoje seu Relatório de Sustentabilidade de 2024, demonstrando progresso significativo em soluções circulares e de baixo carbono, ação …

LyondellBasell rafforza la leadership in materia di sostenibilità con il suo Rapporto di Sostenibilità 2024: “From Vision to Value”
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), leader globale nell'industria chimica, ha pubblicato oggi il suo Rapporto sulla Sostenibilità 2024, confermando progressi significativi nell’ambito delle soluzioni circolari e a basse …

LyondellBasell versterkt duurzaam leiderschap in Duurzaamheidsrapport 2024: van visie naar waarde
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB), een leider in de wereldwijde chemische industrie, heeft vandaag zijn duurzaamheidsrapport van 2024 gepubliceerd, waarin staat dat er aanzienlijke vooruitgang is geboekt in circulaire …

利安德巴赛尔 2024 年可持续发展报告彰显可持续发展领导力:从愿景到价值
休斯顿, April 15, 2025 (GLOBE NEWSWIRE) -- 全球化⼯⾏业的头部企业利安德巴赛尔 (NYSE: LYB) 今天发布了 2024 年可持续发展报告:从愿景到价值 (2024 Sustainability Report: From Vision to Value) ,展示其在循环和低碳解决⽅案、⽓候⾏动和卓越运营⽅⾯取得的重⼤进展。 利安德巴赛尔⾸席执⾏官 Peter Vanacker 表示:“在 LYB,可持续发展是重新构想未来和创造⻓期价值的机会。2024 …

zSpace Acquires Second Avenue Learning to Revolutionize Experiential Education
SAN JOSE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc., a leading provider of augmented and virtual reality (AR/VR) solutions for education, proudly announces the acquisition of Second Avenue Learning, a Rochester, NY-based innovator in …

Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity …

AgEagle Showcases eBee VISION Drone at 173rd Airborne Brigade Innovation Symposium
Private event featured demonstrations and roundtable discussions with key members of the armed forces and key decision makers WICHITA, Kan., April 15, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS) (“AgEagle” or the “Company”), a leading …

Aspargo Labs CEO to Participate in Panel Discussion at the American Urological Association Innovation Nexus Conference
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a Pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in proprietary …

Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates
WARRINGTON, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported …

Chemomab Announces New Medical and Clinical Appointments
David M. Weiner, MD, Rejoins Chemomab as Interim Chief Medical Officer, Bringing Extensive Biotechnology and Pharmaceutical Industry R…

TransGlobal Assets Inc. (OTC: TMSH) and The Now Corporation (OTC: NWPN) Strike Strategic Deal to Commercialize Acclaimed Works by Michael Berman
Strategic IP Partnership Expands Literary Works into Multimedia: TransGlobal Assets Inc. (OTC: TMSH), through Mindwell Solutions Group, has signed an exclusive global media rights deal with The Now Corporation (OTC: NWPN) to adapt and commercialize the …

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
All proposals of Board of Directors approved Gilbert Ghostine re-elected as Chairman of Board of Directors; all other Board members standing for re-election confirmed Dividend of CHF 0.60 per registered dividend-paying share approved, representing 24% of …

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly prevalent ocular diseases, today reported financial …

Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that the U.S. Food and Drug …

Zions Bancorporation to Implement nCino Platform and Intelligent Solutions as the Technology Foundation of its Lending End-to-End Process Transformation
WILMINGTON, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that Zions Bancorporation has selected nCino as its technology platform as they digitally …

Dyne Therapeutics Announces Chief Business Officer and Chief Scientific Officer Appointments
- Vikram Ranade, PhD, appointed as chief business officer - - Ranjan Batra, PhD, appointed as chief scientific officer - - Oxana Beskrovnaya, PhD, transitioning to chief innovation officer - WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Dyne …

Mawson Infrastructure Group Inc. Announces Participation in Upcoming Conferences and Events
MIDLAND, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ: MIGI) ("Mawson" or "the Company"), a publicly-traded technology company focused on digital infrastructure platforms for artificial intelligence (AI), high- …

Repligen to Report First Quarter 2025 Financial Results
WALTHAM, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its first quarter 2025 financial results on Tuesday, April 29, 2025. The Company will issue a press release before the market …

Plus Therapeutics Presents New Data Highlighting Clinical Benefit and Safety of REYOBIQ in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases
HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …

A quarter of Gen Z now pays for social media
SAN JOSE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- In a surprising twist to the once-free world of social media, nearly a quarter (23%) of Gen Z Americans (aged 18-25) now pay for a subscription to social media platforms such as Snapchat and X. That’s …